Disparities and Delay in the Use of Guideline-Based Antiretroviral Therapy for Treatment of Pregnant Women with HIV in the Southeast United States.
作者信息
Cohn Ellery R, Korte Jeffrey E, Lazenby Gweneth B
机构信息
College of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina.
出版信息
AIDS Patient Care STDS. 2019 Sep;33(9):381-383. doi: 10.1089/apc.2019.0147. Epub 2019 Aug 16.
Abstract
摘要
相似文献
1
Disparities and Delay in the Use of Guideline-Based Antiretroviral Therapy for Treatment of Pregnant Women with HIV in the Southeast United States.美国东南部地区在使用基于指南的抗逆转录病毒疗法治疗感染艾滋病毒的孕妇方面存在的差异和延误
AIDS Patient Care STDS. 2019 Sep;33(9):381-383. doi: 10.1089/apc.2019.0147. Epub 2019 Aug 16.
2
Antiretroviral Prescribing Practices Among Pregnant Women Living With HIV in the United States, 2008-2017.美国 HIV 感染者孕妇 2008-2017 年抗逆转录病毒药物处方实践
JAMA Netw Open. 2019 Dec 2;2(12):e1917669. doi: 10.1001/jamanetworkopen.2019.17669.
3
Initiation of antiretroviral therapy or antiretroviral prophylaxis in pregnant women living with HIV registered in five townships of Mandalay, Myanmar: A cross sectional study.在缅甸曼德勒五个镇区登记的 HIV 阳性孕妇中启动抗逆转录病毒治疗或抗逆转录病毒预防：一项横断面研究。
BMC Pregnancy Childbirth. 2019 Dec 5;19(1):475. doi: 10.1186/s12884-019-2627-6.
4
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
5
U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.美国公共卫生服务部特别工作组关于在感染HIV-1的孕妇中使用抗逆转录病毒药物以促进孕产妇健康及采取干预措施减少美国围产期HIV-1传播的建议。
MMWR Recomm Rep. 2002 Nov 22;51(RR-18):1-38; quiz CE1-4.
6
Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.美国公共卫生服务工作组关于在感染HIV-1的孕妇中使用抗逆转录病毒药物以保障孕产妇健康和减少围产期HIV-1传播的建议。疾病控制与预防中心。
MMWR Recomm Rep. 1998 Jan 30;47(RR-2):1-30.
7
Hospitalizations of pregnant HIV-infected women in the United States in the era of highly active antiretroviral therapy (HAART).高效抗逆转录病毒治疗（HAART）时代美国感染艾滋病毒的孕妇的住院情况。
J Womens Health (Larchmt). 2007 Mar;16(2):159-62. doi: 10.1089/jwh.2006.CDC2.
8
Racial/ethnic disparities in antiretroviral treatment among HIV-infected pregnant Medicaid enrollees, 2005-2007.2005-2007 年，感染 HIV 的孕妇中接受抗逆转录病毒治疗的种族/民族差异：医疗补助计划参保者。
Am J Public Health. 2013 Dec;103(12):e46-53. doi: 10.2105/AJPH.2013.301328. Epub 2013 Oct 17.
9
Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.抗逆转录病毒初治和经治的 HIV 感染孕妇在高效抗逆转录病毒治疗下达到病毒载量抑制的时间：对妊娠晚期就诊孕妇的影响。
BJOG. 2013 Nov;120(12):1534-47. doi: 10.1111/1471-0528.12226. Epub 2013 Aug 7.
10
Trends in hospitalizations of pregnant HIV-infected women in the United States: 2004 through 2011.2004年至2011年美国感染艾滋病毒的孕妇住院情况趋势
Am J Obstet Gynecol. 2016 Oct;215(4):499.e1-8. doi: 10.1016/j.ajog.2016.05.048. Epub 2016 Jun 2.
本文引用的文献
1
The Impact of Delivery in a Rural County on a Cohort of Women Living with HIV Infection and Their Infants.农村地区分娩对感染 HIV 的女性及其婴儿队列的影响。
J Rural Health. 2019 Jun;35(3):319-329. doi: 10.1111/jrh.12312. Epub 2018 Jul 16.
2
Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies.多替拉韦利匹韦林治疗成人 HIV-1 病毒学抑制维持治疗的疗效、安全性和耐受性：III 期、随机、非劣效性 SWORD-1 和 SWORD-2 研究。
Lancet. 2018 Mar 3;391(10123):839-849. doi: 10.1016/S0140-6736(17)33095-7. Epub 2018 Jan 6.
3
Understanding Cross-Sectional Racial, Ethnic, and Gender Disparities in Antiretroviral Use and Viral Suppression Among HIV Patients in the United States.了解美国艾滋病毒患者在抗逆转录病毒药物使用和病毒抑制方面的横断面种族、民族和性别差异。
Medicine (Baltimore). 2016 Mar;95(13):e3171. doi: 10.1097/MD.0000000000003171.
4
Revised surveillance case definition for HIV infection--United States, 2014.修订后的 HIV 感染监测病例定义——美国，2014 年。
MMWR Recomm Rep. 2014 Apr 11;63(RR-03):1-10.
5
A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA.瑞士艾滋病毒队列研究与美国国际艾滋病协会建议的初始抗逆转录病毒治疗的比较。
PLoS One. 2011;6(12):e27903. doi: 10.1371/journal.pone.0027903. Epub 2011 Dec 20.
6
Influence of gender on receipt of guideline-based antiretroviral therapy in the era of HAART.在高效抗逆转录病毒治疗（HAART）时代，性别对接受基于指南的抗逆转录病毒治疗的影响。
AIDS Care. 2012;24(1):20-9. doi: 10.1080/09540121.2011.592814. Epub 2011 Jul 6.
7
Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1).尽管在分娩时母体病毒载量<500 拷贝/ml，但仍与 HIV-1 母婴传播相关的因素：嵌套在法国围产期队列（EPF-ANRS CO1）中的病例对照研究。
Clin Infect Dis. 2010 Feb 15;50(4):585-96. doi: 10.1086/650005.
8
Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV-infected women.美国一组感染HIV的女性中初始抗逆转录病毒疗法与HIV治疗指南的一致性。
J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):377-83. doi: 10.1097/QAI.0b013e318160d552.
9
Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.2001年，在一个多州的HIV患者样本中，接受高效抗逆转录病毒治疗方面的种族和性别差异依然存在。
J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):96-103. doi: 10.1097/00126334-200501010-00017.
10
US Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States, February 25, 2000.2000年2月25日美国公共卫生服务部特别工作组关于感染人类免疫缺陷病毒1型的孕妇使用抗逆转录病毒药物以保障孕产妇健康及减少美国围产期人类免疫缺陷病毒1型传播的建议。
HIV Clin Trials. 2000 Sep-Oct;1(2):39-64. doi: 10.1310/hct.2000.1.2.007.
Zotero 插件